Market Overview
The rising prevalence of cancer across the world is boosting the global histone deacetylase inhibitors market, says Fortune Business Insights in their recent study. The study is titled, “Histone Deacetylase Inhibitors Market Size, Share and Global Trend by Class (Class I HDACs, Class II HDACS, Class III HDACs, Class IV HDACs), Application (Oncology, Neurology), End User (Hospitals, Academic & research institutes, Pharmaceutical companies) and Geography Forecast till 2026,”, and it states the rise in demand for treating cancer has createdlucrative growth opportunities for the market globally.
According to Fortune Business Insights, the cancer segment willaccount for the largest share in the market, due to its rising prevalence. Increasing expenditure on healthcare especially for treatment of cancer is helping the cancer segment lead the market.
Request a Sample Copy of the Research Report
COVID-19 Impact
The number of COVID-19 cases in the world is increasing at an alarming rate, driving the demand for accurate testing kits to identify the number of infected people. As per the World Health Organization (WHO), the number of cases in the US has reached around 59 lakhs in August 2020. Several countries are focusing on developing COVID-19 diagnostic testing kits and procedures to rapidly test, identify, and track coronavirus cases and containthe spread of the virus. Companies such as Roche, Bio-Rad, Thermo Fischer Scientific, CovidMD, and others have developed various technologies and services to enhance the detection of viruses. For example, CovidMD announced the launch of a new virtual video consultant platform for handling potential virus infections in May 2020. It incorporates a Salesforce Service Cloud that offers personal guidance to consumers by studying their health background and provides solutions to avoid infections. The implementation of advanced technologies in detection kits and services is enabling governments to contain the contagion to a certain extent and lessen the suffering of patients, thereby influencing market growth.
Rising Incidence of Cancer Fuels Demand for Histone Deacetylase Inhibitors
Various factors are responsible for the growth of the global histone deacetylase market including the increasing number of cancer cases. Other factors include the presence of skilled professionals in developed regions, increasing number of neurological disorders and tumor cases, and supportive reimbursement policies by governments. As per the World Health Organization, the second major cause of death in the world is cancer. In 2018, cancer was the cause of death in an estimated 9.6 million people around the world.
On the flipside, the market may face challenges in terms of inadequate reimbursement policies. However, rise in awareness about various chronic diseases and the availability of advanced diagnostics for timely diagnosis of such diseases will help the market gain momentum in the coming years.
Quick Buy Global Histone Deacetylase Inhibitors Market
Market to Gain Impetus from Government Reimbursement Policies
From a geographical standpoint, the global histone deacetylase inhibitors market is dominated by North America on account of rising prevalence of neurological disorders and cancer. The American Cancer Society states an estimated 12% of women in the U.S. develop breast cancer during their lifetime. The report also stated an estimate of 2300 men in the U.S. to be diagnosed with breast cancer. This, coupled with, the high acceptance of histone deacetylase inhibitors in developed nations of Canada and the U.S. is likely to help North America continue dominating the market through the forecast period.
On the other hand, markets at Europe and Asia Pacific are anticipated to grow at a faster rate owing to the increasing cases of neurological disordersand the improving healthcare facilities in the respective regions. Besides this, the surge in demand for advanced treatment by a large number of patients is a major factor propelling growth of the market.
Major vendors in the global histone deacetylase inhibitors market are focusing on strategies such as company collaborations, new product launches, mergers and acquisitions. They are also investing huge sums in research and development for creating innovative drugs. To site and instance, interim data of Phase 2 study evaluating pracinostat was announced in December 2018, by Helsinn Healthcare S.A. Pracinostat is a histone deacetylase inhibitor that combines with azacitadine for treating patients suffering from higher stage of Myelodysplastic Syndrome (MDS) or IPSS-R high. Some of the players operating in the global histone deacetylase inhibitors market areAbcam plc.,Cetya Therapeutics, R&D Systems, Inc., Mirati Therapeutics, TCI Chemicals (India) Pvt. Ltd., InvivoGen, BioVision Inc., Medivir AB, and Merck KGaA.
Have Any Query? Ask Our Experts
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
The Global Histone Deacetylase Inhibitors Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the COVID-19 Impact and Recovery on this industry.Browse the complete Global Histone Deacetylase Inhibitors Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027 @ https://www.decisiondatabases.com/ip/6596-histone-deacetylase-inhibitors-market-report The report also covers the complete competitive landscape of the global Histone Deacetylase Inhibitors market with company profiles of key playerssuch as: 4SC AGAcetylon PharmaceuticalsCelleron TherapeuticsChroma TherapeuticsCrystalGenomicsCurisMEI PharmaMirati TherapeuticsNovartisOnxeoRepligenTetraLogicThe detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT: By TypeCompetitive InhibitorsUncompetitive InhibitorsMixed InhibitorsBy ApplicationPsychiatry and NeurologyCancer TreatmentInflammatory DiseasesOther DiseasesBy Geography:North America (NA) – US, Canada, and MexicoEurope (EU) – UK, Germany, France, Italy, Russia, Spain & Rest of EuropeAsia-Pacific (APAC) – China, India, Japan, South Korea, Australia & Rest of APACLatin America (LA) – Brazil, Argentina, Peru, Chile & Rest of Latin AmericaMiddle East and Africa (MEA) – Saudi Arabia, UAE, Israel, South AfricaDownload Free Sample Report of Global Histone Deacetylase Inhibitors Market @ https://www.decisiondatabases.com/contact/download-sample-6596The Global Histone Deacetylase Inhibitors Market has been exhibited in detail in the following chapters –Chapter 1 Histone Deacetylase Inhibitors Market PrefaceChapter 2 Executive SummaryChapter 3 Histone Deacetylase Inhibitors Industry AnalysisChapter 4 Histone Deacetylase Inhibitors Market Value Chain AnalysisChapter 5 Histone Deacetylase Inhibitors Market Analysis By TypeChapter 6 Histone Deacetylase Inhibitors Market Analysis By ApplicationChapter 7 Histone Deacetylase Inhibitors Market Analysis By GeographyChapter 8 Competitive Landscape Of Histone Deacetylase Inhibitors CompaniesChapter 9 Company Profiles Of Histone Deacetylase Inhibitors Industry Purchase the complete Global Histone Deacetylase Inhibitors Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-6596Other Reports by DecisionDatabases.com:Global Interleukin Inhibitors Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027Global Mold Inhibitor Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027Global Plasma Protease C1-inhibitor Treatment Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
Histone Deacetylase Inhibitors Market are chemotherapy agents that inhibit histone deacetylases.
These agents cause apoptosis and cell death.
The drugs show good effects for hematological malignancies and epigenetic or non-epigenetic regulations.Global histone deacetylase inhibitors market is rising gradually with a healthy CAGR of 14.2% in the forecast period of 2020-2027.
The report contains data of the base year 2019 and historic year 2018.
Prevailing cases of neurological disorders and other chronic diseases creates avenues for this market growth Get Sample Report at : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-histone-deacetylase-inhibitors-marketCompetitive Analysis: Global Histone Deacetylase Inhibitors MarketFew of the major competitors currently working in the global histone deacetylase inhibitors market are Midatech Pharma PLC, Crystal Genomics, CELGENE CORPORATION, Novartis AG, Shenzhen Chipscreen Biosciences Co., Ltd., Spectrum Pharmaceuticals, Inc., Merck & Co., Inc., Celleron Therapeutics, FORUM Pharmaceuticals Inc., Pfizer Inc., AstraZeneca, Eisai Co., Ltd., REGENACY PHARMACEUTICALS, LLC, Karyopharm Therapeutics, Aurobindo Pharma, Trovagene, Wellness Pharma International, Syndax, MEI Pharma Inc., Onxeo among others.
Key Pointers Covered in the Global Histone Deacetylase Inhibitors Market Trends and Forecast to 2026Global Histone Deacetylase Inhibitors Market New Sales VolumesGlobal Histone Deacetylase Inhibitors Market Replacement Sales VolumesGlobal Histone Deacetylase Inhibitors Market Installed BaseGlobal Histone Deacetylase Inhibitors Market By BrandsGlobal Histone Deacetylase Inhibitors Market SizeGlobal Histone Deacetylase Inhibitors Market Procedure VolumesGlobal Histone Deacetylase Inhibitors Market Product Price AnalysisGlobal Histone Deacetylase Inhibitors Market Healthcare OutcomesGlobal Histone Deacetylase Inhibitors Market Cost of Care AnalysisGlobal Histone Deacetylase Inhibitors Market Regulatory Framework and ChangesGlobal Histone Deacetylase Inhibitors Market Prices and Reimbursement AnalysisGlobal Histone Deacetylase Inhibitors Market Shares in Different RegionsRecent Developments for Global Histone Deacetylase Inhibitors Market CompetitorsGlobal Histone Deacetylase Inhibitors Market Upcoming ApplicationsGlobal Histone Deacetylase Inhibitors Market Innovators StudyGet Detailed TOC:https://www.databridgemarketresearch.com/toc/?dbmr=global-histone-deacetylase-inhibitors-market Key Developments in the Market:In October 2019, Midatech Pharma PLC received Orphan Drug designation from the U. S. FDA for MTX110, a non-selective histone deacetylase inhibitor used for treatment of patients with malignant glioma and diffuse intrinsic pontine glioma (DIPG).
These agents cause apoptosis and cell death.
Histone deacetylase inhibitors are newer class of anti-cancer drugs used for treatment of T-cell lymphoma and myeloma.
The drugs show good effects for hematological malignancies and epigenetic or non-epigenetic regulations.According to World Health Organization (WHO), approximately 9.6 million deaths are reported in 2018 by cancer which includes lung, prostate, stomach and liver cancer as the most common types of cancers.
The report contains data of the base year 2019 and historic year 2018.
Prevailing cases of neurological disorders and other chronic diseases creates avenues for this market growthThis Histone Deacetylase Inhibitors Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.
The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market.
The Histone Deacetylase Inhibitors Market Report, in its latest update, highlights the significant impacts and the recent strategical changes under the present socio-economic scenario.
The Histone Deacetylase Inhibitors industry growth avenues are deeply supported by exhaustive research by the top analysts of the industry.
The report starts with the executive summary, followed by a value chain and marketing channels study.
The report then estimates the CAGR and market revenue of the global and regional segments.Base Year: 2020Estimated Year: 2021Forecast Till: 2027The report classifies the market into different segments based on type and product.
These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels.
The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.Get | Download FREE Sample Report of Global Histone Deacetylase Inhibitors Market @ https://www.decisiondatabases.com/contact/download-sample-6596A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Histone Deacetylase Inhibitors market.
